ArriVent BioPharma (AVBP) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order at 12:00 P.M. Eastern Time on June 18, 2026, and held virtually to improve stockholder access.

• The agenda was made available online, with opportunities for questions on proposals and a general Q&A at the end.

• Attendees were reminded to follow the rules of conduct, and key company representatives and advisors were introduced.

Board and executive committee updates

• Directors present included John Hohneker, Chris Nolet, Merdad Parsey, and Kristine Peterson.

• Nominees for re-election were James Haley, John Hohneker, and Merdad Parsey.

Corporate governance

• A quorum was established with 72.07% of outstanding voting stock represented.

• Most proxies authorized votes for management's director nominees.